A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/19/2017 |
| Start Date: | January 6, 2016 |
| End Date: | September 9, 2016 |
A Multicenter, Double-masked, Randomized Study to Compare the Safety and Efficacy of the OM3 Tear Formulation With REFRESH OPTIVE® ADVANCED Unit Dose for 3 Months in Patients With Dry Eye Disease
This study will evaluate the safety and efficacy of a new eye drop formulation in patients
with dry eye disease.
with dry eye disease.
Inclusion Criteria:
- Used artificial tears for dry eye
- Visual acuity of at least 20/32 (while wearing glasses, if necessary).
Exclusion Criteria:
- Use of contact lenses in the last 3 months, or anticipated use of contact lenses
during the study
- Herpes keratitis in the last 6 months
- Cataract surgery, laser-assisted in situ keratomileusis [LASIK], or photorefractive
keratectomy, within the last 6 months
We found this trial at
11
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials